Press Releases
Press Releases published on August 9, 2023 in Practical Issues for Pharmacists
On July 19, 2023, an EF3 tornado touched down in Rocky Mount, NC, badly damaging a Pfizer drug manufacturing facility that is responsible for producing nearly 25% of Pfizer’s sterile injectable medicines used in US hospitals.
Press Releases published on January 5, 2016
Succeeding in today’s crowded healthcare market often requires that associations align with like-minded organizations to achieve their goals. It is this realization that has led to a strategic partnership between The Lynx Group and the National Association of Specialty Pharmacy (NASP).
Press Releases published on July 6, 2015
The Academy of Oncology Nurse & Patient Navigators® (AONN+) is proud to announce that it has been granted membership in the American College of Surgeon’s Commission on Cancer.
Press Releases published on July 1, 2014
Onco360, the largest independent provider of Oncology Pharmacy Services in the U.S., announced today that Bill Gittinger has joined the organization as a National Director for its Managed Care business.
Press Releases published on February 17, 2014
New York – February 12, 2014 – Onco360, the nation’s fastest-growing independent Oncology Pharmacy and Clinical Support Services company, is proud to be part of the limited Specialty Pharmacy Network of IMBRUVICA™ (ibrutinib).
Press Releases published on February 17, 2014
New York – February 12, 2014 – Onco360, the nation’s fastest-growing independent Oncology Pharmacy and Clinical Support Services company, is proud to be part of the limited Specialty Pharmacy Network of IMBRUVICA™ (ibrutinib).
Press Releases published on January 21, 2014
The FDA recently approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients with advanced melanoma that is unresectable (cannot be removed by surgery) or metastatic (late-stage).
Press Releases published on January 21, 2014
The FDA recently approved Mekinist (trametinib) in combination with Tafinlar (dabrafenib) to treat patients with advanced melanoma that is unresectable (cannot be removed by surgery) or metastatic (late-stage).
Press Releases published on December 9, 2013
Onco360 Expected to Rapidly Grow Revenues Over the Next Several Years
Press Releases published on December 9, 2013
Onco360 Expected to Rapidly Grow Revenues Over the Next Several Years
- 1
- 2
Page 1 of 2
Results 1 - 10 of 11
Results 1 - 10 of 11